Literature DB >> 28978951

Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder.

Brooks D Cash1, Brian E Lacy2, Philip S Schoenfeld3, Leonard S Dove4, Paul S Covington5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28978951     DOI： 10.1038/ajg.2017.257

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Influence of cholecystectomy on sphincter of Oddi motility.

Authors:  W Luman; A J Williams; A Pryde; G D Smith; S J Nixon; R C Heading; K R Palmer
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

2.  Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.

Authors:  Nicholas S Downing; Nilay D Shah; Jenerius A Aminawung; Alison M Pease; Jean-David Zeitoun; Harlan M Krumholz; Joseph S Ross
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

3.  Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Authors:  Brooks D Cash; Brian E Lacy; Philip S Schoenfeld; Leonard S Dove; Paul S Covington
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 4.  Sphincter of Oddi Function and Risk Factors for Dysfunction.

Authors:  Elham Afghani; Simon K Lo; Paul S Covington; Brooks D Cash; Stephen J Pandol
Journal:  Front Nutr       Date:  2017-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.